Moreover, HDAC1’s role in maintaining the self-renewal potential of GBM cancer stem cells complicates treatment efforts, as these cells exhibit resistance to standard therapies (Lo et al., 2021). This evidence concerns the gene HDAC1 and glioblastoma.